• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. PROXIMATE*HCS HEMORR CIR STAPL; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. PROXIMATE*HCS HEMORR CIR STAPL; STAPLE, IMPLANTABLE Back to Search Results
Catalog Number PPH01
Health Effect - Clinical Codes Pain (1994); Blood Loss (2597); Not Applicable (3189); No Code Available (3191)
Date of Event 01/01/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Publication year of 2018.Batch # unk.This report is related to a journal article; therefore, no product will be returned for analysis and the manufacturing records cannot be reviewed as the lot/batch number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the author/surgeon believe that the ethicon device caused or contributed to the patient complications mentioned in the article? if yes, please explain.(b)(4).
 
Event or Problem Description
It was reported via literature entitled: clinical outcomes of stapled transanal rectal resection for obstructed defaecation syndrome at 10-year follow-up authors: m.Schiano di visconte, f.Nicoli, a.Pasquali and g.Bellio citation: colorectal disease (2018); 2:614¿622.Doi:10.1111/codi.14028.The primary aim of this study was to evaluate the clinical outcomes and patients¿ satisfaction after stapled transanal rectal resection (starr) for obstructed defaecation syndrome (ods) at 10-year follow-up.The secondary aim was to define factors that predict the recurrence of ods after starr.This study was a retrospective cohort analysis conducted on prospectively collected data.Seventy-four consecutive patients (8 male and 66 female; mean age: 60.0 ±10.2; age range: 29-77 years) who underwent starr for ods between january 2005 and december 2006 in two italian hospitals were included.Three semi-circumferential purse-string sutures were placed in the anterior rectal wall and a 33-mm circular stapler (pph-01; ethicon) was inserted, closed and fired.Two semi-circumferential purse string sutures were positioned in the posterior rectal wall and a second pph-01 (ethicon) stapler was used.Reported complications included rectal bleeding (n-14) in which 7 patients were successfully managed conservatively and granulomatous foreign body reaction at the staple line (n-7) which required removal at the outpatient clinic.Reported complications during 3- month follow up included perineal pain (n-25) which were treated initially with painkillers (paracetamol or ketoprofen), 4 patients required staple line removal and mucosal layer reconstruction with resorbable suture, 4 patients were treated with nifedipine and 2 patients required chronic oral analgesics, urge to defecate (n-21) in which 13 patients were treated with biofeedback, oral gabapentin and beclomethasone suppositories without a significant improvement in symptoms and 3 patients were treated with sacral neuromodulation after conservative treatment failure with poor results, soiling (n-7), gas leakage (n-4), liquid leakage (n-1).At 12-month follow up, reported complications included perineal pain (n-21) which were treated initially with painkillers (paracetamol or ketoprofen), 4 patients required staple line removal and mucosal layer reconstruction with resorbable suture, 4 patients were treated with nifedipine and 2 patients required chronic oral analgesics, urge to defecate (n-14) in which 13 patients were treated with biofeedback, oral gabapentin and beclomethasone suppositories without a significant improvement in symptoms and 3 patients were treated with sacral neuromodulation after conservative treatment failure with poor results, soiling (n-5), gas leakage (n-3).At 3 ¿ year follow up, reported complications included perineal pain (n-14), urge to defecate (n-14), soiling (n-3), gas leakage (n-3), liquid leakage (n-3), ods recurrence (n-6), at 5 ¿ year follow up, reported complications included perineal pain (n-11), urge to defecate (n-13), soiling (n-3), gas leakage (n-3), solid leakage (n-1), ods recurrence (n-18).At 10-year follow up, reported complications included perineal pain (n-23), urge to defecate (n-13), soiling (n-4), gas leakage (n-4), liquid leakage (n-1), solid leakge (n-1), recurrence (n-24) in which 6 patients required laparoscopic ventral mesh rectopexy, 2 patients required transabdominal repair with rectal fixation, 2 patients required transvaginal posterior colpoperineorrhaphy and 1 patient required laparoscopic ventral mesh rectopexy along with starr.In conclusion, stapled transanal rectal resection significantly improves the symptoms of ods in the short term.In the long term starr is less effective, however.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
MDR Report Key8862219
Report Number3005075853-2019-20932
Device Sequence Number2390507
Product Code GDW
UDI-Device Identifier10705036012993
UDI-Public10705036012993
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
K030925
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,literature
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberPPH01
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/15/2019
Initial Report FDA Received Date08/05/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
-
-